Skip to content
Open access

Zearalenone acts as a molecular glue to promote K33-linked ubiquitination and degradation of PPARγ and Its effects on glucose metabolism are mitigated by C3G.

Oct 2026 · Environment International · Vol 217, pp. 110585 · 0 citations · 51 references
Medicine

TL;DR

It is demonstrated that ZEA functions as a molecular glue, facilitating K33-linked polyubiquitination and proteasomal degradation of PPARγ, thereby suppressing its transcriptional activity and downstream glycolytic gene expression and highlighting C3G as a potential dietary antagonist that safeguards PPARγ stability and glucose homeostasis against ZEA insults.

Abstract

Zearalenone (ZEA) is a prevalent food-borne mycotoxin associated with metabolic disorders, yet its direct protein targets and the underlying mechanisms of its glucotoxic effects remain largely elusive. Here, we identify peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target of ZEA and demonstrate that ZEA exposure induces a mismatch between PPARγ transcription and protein abundance by promoting its ubiquitination, revealing a novel mechanism underlying ZEA-induced disruption of glucose homeostasis. In vivo, mice exposed to low-dose ZEA (0.5 mg/kg·bw, 5 days) or chronic ZEA combined with a high-fat diet exhibited significant glucose metabolic impairment, which was effectively ameliorated by co-administration of cyanidin-3-O-glucoside. Mechanistically, using HepG2 cells and HEK293T cells co-transfected with hPPARγ and HA-tagged ubiquitin mutants, combined with co-immunoprecipitation, cellular thermal shift assay, drug affinity responsive target stability, microscale thermophoresis, glucose uptake assays, and immunofluorescence, we demonstrate that ZEA functions as a molecular glue, facilitating K33-linked polyubiquitination and proteasomal degradation of PPARγ, thereby suppressing its transcriptional activity and downstream glycolytic gene expression. Notably, C3G competitively binds to PPARγ, preventing ZEA-induced ubiquitination and stabilizing PPARγ protein levels, which restores glucose metabolic function. Furthermore, ZEA-mediated PPARγ depletion partially blunts the therapeutic efficacy of rosiglitazone, a PPARγ agonist, whereas C3G supplementation rescues this effect. Collectively, our findings uncover an unprecedented molecular-glue mechanism for mycotoxin-induced metabolic toxicity and highlight C3G as a potential dietary antagonist that safeguards PPARγ stability and glucose homeostasis against ZEA insults.

Read PDF

Similar papers

Oct 2026

PPARγ Is Critical for Lycopene Antagonizing Zearalenone-Induced Ferroptosis by Promoting Autophagy-Mediated TFRC Degradation in Swine Testicular Cells.

Mycotoxins are common contaminants in agricultural products and feed, which pose a serious threat to public health. Zearalenone (ZEA) is a well-known environmental endocrine disruptor that causes reproductive disorders. Lycopene (LYC) is a possible therapeutic and preventive agent for male diseases. Here, we aim to exp...

Xin-Yue Mao, Zi-Yan Hu, Xin Yao et al. · 0 citations
Oct 2026

WTAP/YTHDC1-mediated m6A modification of P4HA1 suppresses hepatic gluconeogenesis and ameliorates MASLD by activating AKT signaling.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global metabolic epidemic with limited therapeutic options. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) has been implicated in glucose metabolism, but its functional role and regulatory mechanisms in MASLD remain unknown. In this study, we establish...

Xia Cai, Xiao-Jin Xu, Mo-Ran Zhang et al. · 0 citations
Nov 2026

Jujuboside A ameliorates T2DM-associated MASH: Suppression of YY1/FAS axis-mediated hepatic de novo fatty acid biosynthesis.

Metabolic dysfunction-associated steatohepatitis (MASH) in type 2 diabetes mellitus (T2DM) represents a progressive subtype of metabolic dysfunction-associated steatotic liver disease (MASLD), and is predominantly driven by dysregulated hepatic fatty acid (FA) metabolism. Although Jujuboside A (Ju A), a major bioactive...

Ting-Ting Yang, Li-Bang Chen, Hao-Nan Luo et al. · 0 citations
Open access Sep 2026

Demethylzeylasteral Targets the Sp1/AGAP2 Axis to Impair Autophagic Flux and Induce Apoptosis in Hepatic Stellate Cells.

BACKGROUND AND AIM Chronic liver injury-induced liver fibrosis, if left untreated, can progress to cirrhosis or hepatocellular carcinoma, posing a serious threat to human health. Our previous study demonstrated that the natural product demethylzeylasteral (T-96) alleviates liver fibrosis by suppressing ArfGAP with GTPa...

Cheng-Long Wu, Jie Gao, Bo Gao et al. · 0 citations
Open access Oct 2026

Cinnamic Acid Attenuates Ethanol-Exacerbated Hepatocyte Pyroptosis in Type 2 Diabetes via AMPK-Mediated NLRP3/GSDMD Inhibition.

Type 2 diabetes mellitus (T2DM) is frequently accompanied by chronic ethanol (ET) consumption, which worsens metabolic dysregulation and organ damage. Cinnamic acid (CA), a natural compound with anti-diabetic and hepatoprotective effects, shows therapeutic potential, but its role in mitigating ET-exacerbated hepatocyte...

Huai-Ying Tang, Qin Xiang, Yue Zhang et al. · 0 citations
Open access Oct 2026

α-Ketoglutarate Promotes Hepatic Steatosis by Enhancing Cidec Stability via Lactylation–Ubiquitination Crosstalk

α-Ketoglutarate (AKG), a key tricarboxylic acid cycle intermediate, is widely consumed as a dietary supplement by healthy individuals for its perceived anti-aging and performance-enhancing benefits. While its antidiabetic and anti-obesity effects have been reported under pathological conditions, the safety profile and...

Rui Yin, Liang-Li Dai, Hong-Qiu Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.